• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与胰岛素抵抗综合征相关的凝血、血小板功能及纤维蛋白溶解异常。

Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance.

作者信息

Schneider David J

机构信息

University of Vermont, Burlington, Vermont 05446, USA.

出版信息

Coron Artery Dis. 2005 Dec;16(8):473-6. doi: 10.1097/00019501-200512000-00003.

DOI:10.1097/00019501-200512000-00003
PMID:16319656
Abstract

Insulin resistance that accompanies obesity, hypertension, polycystic ovary syndrome, and the early phases of type 2 diabetes is characterized by a prothrombotic state. The prothrombotic state is a reflection of the direct effects of hyperinsulinemia and associated metabolic abnormalities (postprandial hyperglycemia, increased free fatty acids, and hypertriglyceridemia) on platelets, coagulation, and fibrinolysis. Therapies that improve insulin sensitivity and thereby decrease insulin resistance, hyperinsulinemia, and metabolic abnormalities decrease the prothrombotic state.

摘要

肥胖、高血压、多囊卵巢综合征以及2型糖尿病早期阶段所伴随的胰岛素抵抗,其特征是处于血栓前状态。血栓前状态反映了高胰岛素血症及相关代谢异常(餐后高血糖、游离脂肪酸增加和高甘油三酯血症)对血小板、凝血和纤溶的直接影响。改善胰岛素敏感性从而降低胰岛素抵抗、高胰岛素血症和代谢异常的疗法,可减轻血栓前状态。

相似文献

1
Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance.与胰岛素抵抗综合征相关的凝血、血小板功能及纤维蛋白溶解异常。
Coron Artery Dis. 2005 Dec;16(8):473-6. doi: 10.1097/00019501-200512000-00003.
2
Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease.在非酒精性脂肪性肝病大鼠模型中,游泳而非维生素E可改善血栓前状态和纤维蛋白溶解功能减退。
J Basic Clin Physiol Pharmacol. 2018 Jan 26;29(1):61-71. doi: 10.1515/jbcpp-2017-0069.
3
Coagulation and fibrinolysis in diabetes.糖尿病中的凝血与纤维蛋白溶解
Semin Vasc Med. 2002 Feb;2(1):75-86. doi: 10.1055/s-2002-23098.
4
Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes.门冬胰岛素和中效胰岛素睡前注射对 2 型糖尿病患者餐后凝血和纤溶的影响。
Diabetes Obes Metab. 2012 May;14(5):447-53. doi: 10.1111/j.1463-1326.2011.01547.x. Epub 2012 Jan 6.
5
Some effects of indomethacin on platelet function, blood coagulation and fibrinolysis.消炎痛对血小板功能、血液凝固及纤维蛋白溶解的某些作用。
Int Z Klin Pharmakol Ther Toxikol. 1971 Oct;5(2):196-9.
6
Insulin, insulin resistance, and platelet signaling in diabetes.糖尿病中的胰岛素、胰岛素抵抗与血小板信号传导
Diabetes Care. 2009 Apr;32(4):528-30. doi: 10.2337/dc08-1942.
7
Short-term supplementation with Aronia melanocarpa extract improves platelet aggregation, clotting, and fibrinolysis in patients with metabolic syndrome.短期补充黑果腺肋花楸提取物可改善代谢综合征患者的血小板聚集、凝血和纤溶。
Eur J Nutr. 2012 Aug;51(5):549-56. doi: 10.1007/s00394-011-0238-8. Epub 2011 Aug 18.
8
[Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis].
Arzneimittelforschung. 1972 Dec;22:Suppl 12A:2219.
9
Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans.高血糖会刺激凝血,而高胰岛素血症会损害健康人的纤维蛋白溶解功能。
Diabetes. 2006 Jun;55(6):1807-12. doi: 10.2337/db05-1543.
10
Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy.胰岛素抵抗和2型糖尿病中血小板对抗聚集剂抵抗的病理生理学:对抗聚集治疗的影响。
Cardiovasc Hematol Agents Med Chem. 2006 Apr;4(2):111-28. doi: 10.2174/187152506776369908.

引用本文的文献

1
A lone spike in blood glucose can enhance the thrombo-inflammatory response in cortical venules.血糖的单次升高会增强皮质小静脉中的血栓炎症反应。
J Cereb Blood Flow Metab. 2024 Feb;44(2):252-271. doi: 10.1177/0271678X231203023. Epub 2023 Sep 22.
2
Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients.阿尔及利亚2型糖尿病患者的血脂谱、肾功能测试及炎症标志物
Iran J Public Health. 2023 Apr;52(4):732-740. doi: 10.18502/ijph.v52i4.12441.
3
Metabolic Syndrome and Cardiometabolic Risk Factors in the Mixed Hypercholesterolemic Populations with Respect to Gender, Age, and Obesity in Asir, Saudi Arabia.
沙特阿拉伯阿西尔地区混合性高胆固醇血症人群中,基于性别、年龄和肥胖情况的代谢综合征和心血管代谢危险因素。
Int J Environ Res Public Health. 2022 Nov 14;19(22):14985. doi: 10.3390/ijerph192214985.
4
Targeting hypercoagulation to alleviate Alzheimer's disease progression in metabolic syndrome.针对代谢综合征中的高凝状态以缓解阿尔茨海默病的进展。
Int J Obes (Lond). 2022 Feb;46(2):245-254. doi: 10.1038/s41366-021-00977-1. Epub 2021 Oct 22.
5
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target.PAI-1 在糖尿病中的作用:病理生理学及作为治疗靶点的角色。
Int J Mol Sci. 2021 Mar 20;22(6):3170. doi: 10.3390/ijms22063170.
6
Clopidogrel resistance response in patients with coronary artery disease and metabolic syndrome: the role of hyperglycemia and obesity.冠状动脉疾病合并代谢综合征患者的氯吡格雷抵抗反应:高血糖和肥胖的作用
J Geriatr Cardiol. 2015 Jul;12(4):378-82. doi: 10.11909/j.issn.1671-5411.2015.04.009.
7
Evaluation of Mean Platelet Volume values in lean women with polycystic ovary syndrome.评价瘦多囊卵巢综合征女性的平均血小板体积值。
Pak J Med Sci. 2014 May;30(3):589-92. doi: 10.12669/pjms.303.4475.
8
Relationship of ovarian volume with mean platelet volume and lipid profile in patients with polycystic ovary syndrome.多囊卵巢综合征患者卵巢体积与平均血小板体积及血脂谱的关系。
Exp Ther Med. 2011 Nov;2(6):1141-1144. doi: 10.3892/etm.2011.327. Epub 2011 Aug 4.
9
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity.纤溶酶原激活物抑制剂 1 调节小胶质细胞的运动和吞噬活性。
J Neuroinflammation. 2012 Jun 29;9:149. doi: 10.1186/1742-2094-9-149.
10
Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study.静脉血栓栓塞症的相关性和后果:爱荷华妇女健康研究。
Am J Public Health. 2010 Aug;100(8):1506-13. doi: 10.2105/AJPH.2008.157776. Epub 2009 Nov 12.